Difference between revisions of "B-cell CLL/lymphoma 2"
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
==See also== | ==See also== | ||
*[[Lymphoma]]. | *[[Lymphoma]]. | ||
*[[Reactive follicular hyperplasia]]. | |||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. | ||
*[[BCL6]]. | |||
==References== | ==References== | ||
Latest revision as of 15:50, 26 April 2022
B-cell CLL/lymphoma 2, officially it is abbreviated BCL2,[1] in an oncogene that was described in the context of CLL. It is expressed in other small cell lymphomas.
Commonly used abbreviations include bcl-2 and BCL-2.